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ABSTRACT 
Sex determination and sexual differentiation are some of the most well studied topics in human 
development. Sex determination is the point where the undifferentiated gonad becomes 
committed to the ovarian or testicular pathway. This event can be triggered genetically or 
environmentally. Sexual differentiation occurs after sexual determination and involves the 
maturation of the gonad, which in turn, coordinates the corresponding physical and behavioral 
phenotypes. Disorders of sexual development (DSD) are among the most common congenital 
abnormalities seen in humans and are increasing at an alarming rate. Congenital DSDs can be 
caused by genetic, hormonal, and/or environmental stimuli. Increased exposure to environmental 
endocrine disrupters (EEDs) especially those that affect estrogen signaling have been shown to 
cause DSDs. In addition to the mouse, the tammar wallaby, Macropus eugenii, has become a 
novel model for studying gonadal differentiation in mammals. Unlike mice, sexual determination 
and differentiation occurs postpartum in the tammar. Furthermore, pouch young are easily 
accessible for surgical and hormonal manipulation. More is known about testicular 
differentiation than ovarian differentiation. Thus, there is a substantial need to create 
transcriptomes as a resource in discovering conserved and novel mechanisms in gonadal 
development. This thesis explores the creation and analyses of these transcriptomes using normal 
male and female developing gonads and estrogen induced ovarian development in male 
marsupial gonads. It will also show that the tammar wallaby is a viable model for studying 
gonadal differentiation and the effects of estrogen in sexual development in mammals. 
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Introduction 
Sex Determination and Sexual Differentiation 
Sex determination and sexual differentiation are some of the best described aspects of human 
development. Sex determination is the event that triggers an undifferentiated gonad to follow 
either a male or female developmental pathway. The mechanisms for sex determination are 
highly variable among the vertebrates and can be either triggered genetically or by 
environmental conditions. Genetic sex determination (GSD) is when the undifferentiated gonad 
depends on intrinsic genetic elements, such as a gene or chromosome to determine its trajectory, 
where as environmental sex determination (ESD) depends on extrinsic environmental cues [1]. 
All mammals including humans have a genetic sex determining system, where a single gene on 
the Y chromosome triggers male development. Sexual differentiation occurs following the sex 
determination event and coordinates development of the mature gonad and the appropriate 
urogenital and behavioral phenotype. Disorders of sexual development (DSD) arise when there 
are problems associated with either the sex determination or sexual differentiation event and are 
the most common congenital conditions in humans. DSDs can be caused by an abnormal 
chromosomal complement, defective gonadal or anatomical development stemming from a 
combination of genetic, hormonal, and/or environmental origins [2,3,4,5]. These disorders range 
from Turner’s syndrome and Klinefelter’s syndrome to gonadal dysgenesis, cryptorchidism and 
hypospadias [2,4]. 
Increasing cases of DSD have been linked to our increasing exposure to environmental endocrine 
disrupters (EEDs). EEDs can be natural or synthetic chemicals that affect the endocrine system 
and can be detrimental to human health especially the process of sexual differentiation. Exposure 
of EEDs such as antiandrogens, estrogens and progestins particularly during pregnancy can 
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cause masculinization in females, feminization in males, decreased sperm count and cancer 
[6,7,8]. For example, diethylstilbestrol (DES), a synthetic estrogen, was used by millions of 
pregnant women during the 1940s to 1970s [6,7]. Exposure of DES to the fetus resulted in many 
forms of DSD ranging from undescended testes, hypospadias, decreased sperm count, vaginal 
hypoplasia, vaginal adenosis, infertility, and other reproductive issues. Additionally, exposure 
increased risk of testicular cancer and clear cell vaginal adenocarcinoma [6,7]. The damaging 
effects of EEDs are not only seen in humans but also in other mammals, fish, birds, reptiles, 
amphibians and crustaceans. Similar effects of DES and other EEDs in humans have been 
demonstrated in mice, rats, rabbits, goats and marsupials. There has been a rise of intersex fish 
and frogs, increased mortality rate and decreased reproductive capacity in fish, birds and 
alligators, and feminization of males and masculinization of females in birds and mollusks [8]. 
Thus, there is a great need to understand the impact these chemicals have on the molecular 
pathways regulating normal sexual development. 
The Marsupial Model 
Many studies have been done utilizing mouse models especially knockout mice to explore 
testicular and ovarian differentiation and the effects of estrogen on these systems. More recently 
marsupial mammals like the gray short-tailed opossum, Monodelphis domestica, and the tammar 
wallaby, Macropus eugenii, are becoming significant model species in the field of sexual 
development. Similar to humans and other eutherian mammals, the tammar wallaby has a XY 
genetic sex determining mechanism. The tammar diverged from humans around 130 to 148 
million years ago [9,10]. Unlike the tammar wallaby, sexual differentiation in humans and other 
eutherian mammals occurs in utero. However, the tammar wallaby gives birth to altricial young 
where sexual differentiation and development occurs postnatally. Easy access to pouch young 
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allows for hormonal and surgical manipulation without the interference of the placenta 
[10,11,12,13].  Many laboratories that use mice to study sexual differentiation have a difficult 
time with hormonal administration due to placental metabolism of hormones. Moreover, sexual 
differentiation occurs at a more rapid rate in utero in comparison to the tammar wallaby, and 
germ cell and somatic cell development occurs simultaneously [1]. Even though mice reproduce 
more rapidly, difficult and time consuming intrauterine surgery must occur to obtain access to 
the fetuses. The tammar wallaby’s unique ability to give birth to altricial young allows for easy 
sex reversal using estradiol and hormonal and surgical manipulation during significant 
developmental time points [14]. All these factors make it advantageous to model DSD using the 
tammar wallaby. 
The majority of the key genes involved in sex determination and sexual differentiation in mice 
have been investigated in marsupials [15,16,17]. While the current data suggests that there are 
some differences in gene expression, the majority of genes behave in an identical manner in 
establishing mouse and marsupial gonadal development. In both eutherian and marsupial 
mammals, sex is determined by the Y-linked SRY gene. The presence of SRY triggers and 
upregulates the expression of SOX9, Sry-type HMG box 9, in both eutherians and marsupials. 
This in turn triggers the development of the testis and initiates the expression of AMH, Anti-
Müllerian hormone. Compared to eutherians, the marsupial X and Y chromosomes are relatively 
small. The tammar X is homologous to the long arm and pericentric region of humans while the 
tammar Y shares just four genes with the human Y [9,10].  
Ovarian Development 
Early research into sexual development including Alfred Jost’s pioneer experiment in rabbits in 
the 1930s suggested that ovarian development was the default sexual developmental pathway. In 
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other words, if the gonad did not receive a dominant signal from the Y-chromosome (SRY) to 
develop a testis, it would passively follow the developmental pathway of the ovary and 
subsequently trigger female sexual development. This led to the Z-factor theory, which 
hypothesizes that a single gene in the female gonad prevents testicular differentiation and 
activates ovarian differentiation. However, recent research suggests otherwise and reveals the 
presence of several pathways working in parallel pathways to coordinate female development. 
R-spondin 1 (RSPO1) is part of the protein R-spondin family, which have been linked to various 
developmental and oncogenic pathways. All R-spondins have an N-terminal signal peptide, two 
furin repeats, one thrombospondin type 1 domain and a C-terminal domain with a nuclear 
localization signal [18]. RSPO1 is particularly important in ovarian differentiation as it represses 
testicular development by activating the canonical WNT/β-catenin signaling pathway [19]. In 
humans, RSPO1 is located on chromosome 1p34.3 and mutations cause female-to-male sex 
reversal, variations of testicular DSD, lack of Müllerian ducts, and palmoplantar hyperkeratosis 
with squamous cell carcinoma of the skin [2,3,4,18,20,21]. Studies of Rspo1 KO in XX mice 
exhibit partial female-to-male sex reversal with the formation of ovotestis and the presence of 
both Wolffian and Müllerian ducts [18,19,22]. The Rspo1 KO gonad showed increased 
expression of the testis markers Sox9, Amh, Fgf9, and Ptgds reiterating its role in suppressing 
male development [22]. The presence of the Wolffian and Müllerian ducts in Rspo1 knockouts 
suggests that RSPO1 is not involved in the development of the mesonephros, which is a 
temporary kidney during embryogenesis and later becomes the Wolffian and Müllerian ducts. In 
addition, it indicates the failure of Sertoli cell development since Amh is not fully produced to 
regress the Müllerian ducts. Knockouts for both Rspo1 and Wnt4 resulted in the inactivation of 
the WNT/β-catenin signaling pathway and the activation of β-catenin rescued Rspo1 KO mice 
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from phenotype mentioned above [18,19]. Deactivating any part of the WNT/β-catenin signaling 
pathway results in female-to-male sex reversal and vice versa when activating the pathway in 
males. During early development, RSPO1 expression levels were both low in male and female 
wallabies until day 4 postpartum where levels increased in females and decreased in males. This 
follows with ovarian differentiation occurring in the tammar on day 4. Results in tammar 
wallaby were consistent with those in mice and humans except that RSPO1 could be acting 
downstream of WNT4 and another ovarian gene FOXL2 [16]. 
Forkhead box L2 (FOXL2) is a forkhead/winged helix nuclear transcription factor that was first 
discovered by studies on sex reversed XX goats with polled-intersex syndrome. This led to 
FOXL2 being mapped to human chromosome 3q23 and associated with Blepharophimosis-
Ptosis-Epicanthus Inversus Syndrome (BPES), premature ovarian failure (POF) and XX sterility. 
Unlike in goats, FOXL2 mutations do not cause sex reversal in humans, but 1-3% of all women 
are affected by POF [23,24,25]. FOXL2 is involved in primordial follicle development and 
maintenance suggesting its relevance in ovarian morphogenesis and homeostasis during female 
reproductive life [3,23,26,27,28,29]. Foxl2 mutations in XY mice have no effect on testis 
differentiation, but overexpression inhibits testis formation [24,29]; however, any sort of Foxl2 
mutation in XX mice causes partial female to male sex reversal, granulosa cells to convert into 
sertoli-like cells, and the expression of genes involved in testicular development 
[24,27,28,29,30,31]. Double loss of function mutations of Foxl2 with Wnt4 or Rspo1 still 
resulted in partial sex reversal, but increased the masculinization of ovaries and boosted 
expression of testis-specific genes including Sox9 [24,26]. The interaction between estrogen 
receptor 1 and FOXL2 in mammals, including the tammar wallaby, represses the expression of 
SOX9 through binding to the testis-specific enhancer of SOX9, TESCO [1,24,31]. Along with 
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mice, female wallabies exhibit higher levels of FOXL2 than males suggesting its conserved role 
in ovarian differentiation. During day 5 to 10 postpartum, FOXL2 was upregulated during 
ovarian development in female wallabies. Estrogen exposure in male tammar wallabies resulted 
in sex reversal, decreased expression of testis-specific genes SRY and AMH, lack of nuclear 
SOX9, and increased expression of ovarian genes FOXL2 and WNT4 [16]. 
Wingless-type MMTV integration site family member 4 (WNT4) is part of a family of signaling 
molecules that are involved in embryogenesis. In humans, WNT4 is located on chromosome 
1p35 and duplication in males disrupts testis differentiation and causes sex reversal, hypospadias, 
the presence of Müllerian ducts, and ambiguous external genitalia. Loss of function mutations in 
females induces Müllerian aplasia, hyperandrogenism, and SERKAL syndrome, which is 
described as female to male sex reversal, gonadal dysgenesis, and developmental problems in the 
kidneys, lungs and heart [2,3,17,31]. In conjunction with RSPO1 and β-catenin, WNT4 represses 
testicular differentiation and promotes ovarian differentiation by activating the canonical 
WNT/β-catenin signaling pathway and initiates FOXL2 transcription. This pathway suppresses 
testicular differentiation by preventing the expression of SOX9 and in turn AMH. WNT4 plays 
significant roles in ovarian steroidogenesis, oogenesis, and the development of the urogenital 
system especially the mesonephros and Müllerian ducts [17,25,32,33,34]. Numerous studies 
have observed partial female to male sex reversal in Wnt4 knockout mice indicating that there 
are more genes involved in promoting ovarian differentiation and blocking testicular 
differentiation. Lack of Müllerian ducts was also observed reiterating Wnt4’s importance in its 
development. Double knockout Foxl2 and Wnt4 mice have increased expression of Sox9, Fgf9 
and Amh and have a higher degree of sex reversal than just Wnt4 KO mice [21,25,28,35,36]. 
WNT4 is highly conserved between eutherian mammals and the tammar wallaby; the tammar 
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shares 93.2% amino acid homology with humans and has conserved roles in gonadal 
development. Consistent with the female tammar developmental timeline, WNT4 expression is 
significantly upregulated after day 4 postpartum in comparison to males. XY gonads exposed to 
estrogen exhibited sex reversal, decreased expression of SRY, AMH and FGF9, lack of nuclear 
SOX9 and increased expression of FOXL2 and WNT4 [16,37,38]. 
Estrogen Induced Ovarian Development 
Several different mouse models have been used to study the effects of estrogen on gonadal 
development. Aromatase knockout (ArKO) mice are deficient for the gene CYP19 that encodes 
for aromatase, an enzyme that converts androgens to estrogens. αβERKO mice lack both 
estrogen receptor 1 (ER1 or ERα) and estrogen receptor 2 (ER2 or ERβ) which mediate estrogen 
signaling. Both are required for normal ovarian function and are highly conserved among 
vertebrates [11]. Female (XX) mice from both models exhibit an increase in circulating 
testosterone, increased expression of genes involved in testicular differentiation, presence of 
Sertoli and Leydig cells, and transdifferentiation of the ovary [11,39,40,41]. ArKO mice still 
have intact ERs and can be rescued with exogenous estrogen. Estrogen exposure in non-
mammalian vertebrates like birds, reptiles, amphibians and fish that follow environmental sex 
determination causes male to female sex reversal. This indicates that estrogen is necessary and 
sufficient to cause ovarian development in these vertebrates [11,42]. Studies on eutherian 
mammals reveal estrogen’s importance in ovarian development and differentiation especially 
during folliculogenesis [40,41]. 
As previously mentioned, exogenous estrogen exposure to the marsupial XY gonad results in 
complete sex reversal and ovarian development. Easy accessibility to the tammar pouch young 
and gonadal differentiation occurring right after birth allows for exogenous estrogen treatment. A 
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study published in 2010 by Pask et al. explored the effects of estrogen induced ovarian 
development in the tammar wallaby. Undifferentiated XY tammar gonads were cultured in the 
presence of estrogen. The expression levels of ‘female’ genes WNT4, FOXL2, RSPO1, and FST 
and ‘male’ genes SRY, SOX9, AMH, and FGF9 were evaluated in XX gonads and treated and 
untreated XY gonads from day 25 prenatal to day 10 postpartum. All these genes involved in 
gonadal development are conserved between eutherian and marsupial mammals. During normal 
ovarian differentiation, XX gonads had high expression levels of ‘female’ genes around day 4 
postpartum and low expression levels of ‘male’ genes. During normal testicular differentiation, 
XY gonads had high expression levels of ‘male’ genes around day 1 postpartum and low 
expression levels of ‘female’ genes. These high expression time points represent when ovarian 
differentiation and testicular differentiation, respectively, occurs during tammar gonadal 
development. 
As expected, expression levels of genes involved in ovarian differentiation especially WNT4 and 
FOXL2 were upregulated and testicular genes were downregulated in the estrogen treated XY 
gonads. However, SOX9 expression levels remained the same in both the untreated and treated 
estrogen XY gonads. Immunohistochemistry revealed ovarian-like structures such as cortex and 
medulla in the treated gonads and lack of testicular cord formation. In addition, SOX9 was found 
in the cytoplasmic regions of gonadal cells unlike the control gonads which had nuclear SOX9. 
This nuclear exclusion of SOX9 in the estrogen cultured gonads prevents the upregulation of 
SOX9 and AMH leading to ovarian development. As previously mentioned, FOXL2 along with 
estrogen receptors blocks the expression of SOX9 and AMH to induce ovarian differentiation and 
repress testicular differentiation. These findings reveal a potential mechanism by which estrogen 
could prevent testicular development and a conserved role of estrogen in vertebrates in thwarting 
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SOX9 nuclear translocation in the ovary. The absence of estrogen results in nuclear SOX9 and 
therefore the initiation of testicular development. However, the precise mechanism by which 
estrogen prevents nuclear translocation of SOX9 is still unclear [16]. This study offers some 
insight into the effects of environmental estrogen exposure on gonadal development and 
differentiation in humans. 
The tammar wallaby can be used a novel model to understand ovarian development, which is 
still poorly understood compared to testicular development. These marsupials can also be used to 
define the effects of estrogen on the development of the gonad. Recently, the genome has been 
sequenced enhancing the utility of the tammar as a genetic model by Renfree et al. 2010. Due to 
the increase in disorders of sexual development in humans, there is a considerable need to 
understand gonadal development. Thus, we performed transcriptomics of the normal developing 
gonads in both males and females as well as for gonads undergoing estrogen induced sex 
reversal. This transcriptome resource will be especially important in identifying novel and 
conserved mechanisms of sexual development. This thesis describes the creation, validation and 
analyses of these libraries. It also shows that the tammar wallaby is a viable alternative model for 
studying gonadal differentiation and the effects of estrogen in sexual development in mammals. 
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Table 1. A Selection of Key Genes with Significantly Affected Expression in Sexual 
Development in Mammals 
Gene Role(s) Human diseases/conditions References 
AMH regression of the Müllerian 
ducts; supports testicular 
differentiation; development 
of epididymis, vas deferens, 
and seminal vesicle 
Persistent Müllerian duct syndrome, 
gonadal dysgenesis, ovotesticular 
DSD 
2,14,15,35,43 
FOXL2 primordial follicle 
development and ovarian 
homeostasis; represses 
testicular differentiation 
Blepharophimosis-Ptosis-Epicanthus 
Inversus Syndrome and premature 
ovarian failure, XX sterility 
3,23,26,27,28 
RSPO1 activation of WNT/β-catenin 
signaling pathway in ovarian 
differentiation; represses 
testicular differentiation 
sex reversal, testicular DSD, 
palmoplantar hyperkeratosis with 
squamous cell carcinoma 
2,3,4,18,19,20, 
21 
SOX9 Sertoli cell development; 
promotes testicular 
differentiation 
Campomelic dysplasia, sex reversal, 
gonadal dysgenesis 
3,21,25,44,45 
SRY initiates and supports 
testicular differentiation 
sex reversal, gonadal dysgenesis 2,3,5,20,21,31, 
46,47  
WNT4 activation of WNT/β-catenin 
signaling pathway in ovarian 
differentiation; represses 
testicular differentiation; 
oogenesis; ovarian 
steroidogenesis; urogenital 
development 
SERKAL syndrome, sex reversal, 
testicular DSD, Müllerian aplasia, 
hyperandrogenism 
2,3,17,25,31,32,
33,34 
 
 
Materials and Methods 
Animals 
Tammar wallabies (Macropus eugenii) from Kangaroo Island of South Australia were 
maintained in our breeding colony in grassy outdoor enclosures. Fetal sex was determined 
through PCR by SRY; pouch young sex was determined through the presence of scrotal bulges or 
mammary primordial [48]. Male and female fetal tammar wallaby gonads were dissected and 
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snap frozen in liquid nitrogen from fetal day 24, 25, and 26 embryos and from days 0, 1, 2, 4, 
and 8 postpartum pouch young. Husbandry, handling and experiments were in accordance with 
the National Health and Medical Research Council of Australia (2004) guidelines and approved 
by the University of Melbourne Animal Experimentation Ethics Committees. 
 
Treatment of Estradiol in Culture 
The gonads were cultured at the University of Melbourne as described as follows. Pairs of 
gonadal ridges were cultured from day 25 of gestation from XY-male tammar wallaby fetuses. 
The tammar wallaby gonadal ridge first develops on day 21 of the 26.5-day gestation period 
[11,16]. Testicular differentiation occurs around day 2 postpartum, and ovarian differentiation 
occurs around day 8 postpartum [11,16]. Pairs of gonads were isolated and placed, one into 
control media and the other into estrogen media for five days. The control media contained 
Dulbecco’s modified Eagle medium (DMEM) with 10% fetal calf serum (FCS) and 50 mg/ml 
ampicillin. The estrogen media used the control media with the addition of estradiol benzoate (to 
a final concentration of 100 ng/ml). Estradiol benzoate was diluted in 100% ethanol (without 
estradiol) was added to control cultures. After five days, the gonads were snap-frozen and stored 
at -80°C until needed for RNA extraction. 
 
RNA Extraction 
Total RNA was extracted from snap frozen tammar wallaby gonads using the GenEluteTM 
Mammalian Total RNA Miniprep Kit (Sigma Cat. no. RTN10) as per manufacturer’s 
instructions. Total RNA was DNase treated using the TURBO DNA-freeTM Kit (Ambion Cat. no.  
AM1907) as per manufacturer’s instructions. Total RNA was stored at -80°C until needed. 
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Concentrating RNA 
The total volume of each RNA sample for each developmental time point and each sex was 
pooled and concentrated into 25 µl using the RiboMinusTM Concentration Module (Invitrogen 
Cat. no. K1550-05) as per manufacturer’s instructions. Concentrated total RNA was stored at -
80°C until needed. 
 
Removal of Ribosomal RNA 
Ribosomal RNA was removed from 24 µl of concentrated total RNA using the Ribo-ZeroTM 
Magnetic Kit (Human/Mouse/Rat; Epicentre Cat. no. MRZH11124) as per manufacturer’s 
instructions. While treating the samples with rRNA Removal Solution, 0.5 µl of 1:10 dilution of 
ERCC RNA Spike-In Control Mixes (Ambion Cat. no. 4456740, 4456739) was added to each 
sample. After rRNA removal, the samples were purified using the RNeasy MinElute Cleanup Kit 
(Qiagen Cat. no. 74204) as per manufacturer’s instructions. The concentration of the sample was 
determined using the NanoDrop 1000 Spectrophotometer. Total RNA was stored at -80°C until 
needed. 
 
Table 2. List of Samples Used for RNA Sequencing Library 
Sample Number of 
gonads 
extracted 
ERCC RNA 
Spike-In 
Control Mix 
Concentration 
(ng/µl) 
Amount (µl) Total RNA 
(ng) 
d24♀ 6 1 10.4 9 93.6 
d25♀ 7 2 13.2 9 118.8 
d26♀ 8 1 10.8 9 97.2 
D0♀ 7 1 16.7 9 150.3 
D4♀ 16 2 10.8 9 97.2 
D8♀ 6 2 8.1 9 72.9 
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d24♂ 7 1 27.5 11 302.5 
d25♂ 9 1 5.5 11 60.5 
d26♂ 7 1 12.8 11 140.8 
D0♂ 7 1 12.2 11 134.2 
D1♂ 6 2 12.1 10 121 
D2♂ 14 1 and 2 13.7 10 137 
D4♂ 6 2 5.9 10 59 
control d25♂ 
untreated 
6 1 33.19 9 298.7 
E2 d25♂ 
treated 
6 2 5.63 9 50.7 
 
Note: Samples with a lowercase ‘d’ indicate developmental time points during gestation. 
Samples with an uppercase ‘D’ indicate developmental time points postpartum. 
 
Library preparation and sequencing 
RNA sequencing and preparation was outsourced to PerkinElmer in Branford, Connecticut. The 
Illumina HiSeq 2000 sequencing system was used with HiSeq Flow Cell v3, TruSeq SBS Kit v3, 
TruSeq PE Cluster Kit v3-cBot-HS, and TruSeq Multiplex Sequencing Primer Box as per 
manufacturer’s instructions. 
 
Data Analysis 
FastQC was used to check the quality of the raw high throughput mRNA sequencing reads 
obtained from PerkinElmer as per manufacturer’s instructions. 
The Bowtie suite published by Trapnell et al. 2012 was used to annotate the transcriptomes, 
discover novel genes and to test for differential gene expression. The reads were adapter trimmed 
and quality filtered using TrimGalore. Reads that were smaller than 20 bp were discarded. The 
samples were then mapped to rRNA sequences using Bowtie2, and the remaining reads were 
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then mapped to an unpublished unannotated tammar assembly as a reference genome using 
TopHat2. The aligned reads from TopHat2 were then independently assembled to identify 
putative genes using Cufflinks using the option for stranded reads. Cuffmerge was used to merge 
the independent assemblies. Genes were identified using BLASTX to search RefSeq, with the 
match with the lowest e-value being selected as the identity of the gene. Differentially expressed 
genes and transcripts were identified utilizing Cuffdiff. Lastly, CummbeRbund provided 
visualized expression data supplied by Cuffdiff [49]. 
In addition to the Bowtie suite, BLASTX aided in the search for protein coding genes and 
Blast2GO annotated the results as per manufacturer’s instructions. 
 
Results 
Table 3. Summary of Sequencing Results 
Sample Yield (GB) # of Reads (million) % Reads Q >= 30 Mean Q Score 
d24♀ 13.39 133.9 84.29 33.74 
d25♀ 13.14 131.44 84.44 33.79 
d26♀ 13.88 138.78 84.4 33.77 
D0♀ 12.51 125.14 84.57 33.8 
D4♀ 15.04 150.38 85.14 34.01 
D8♀ 11.69 116.93 84.79 33.9 
d24♂ 11.63 116.28 82.32 33.14 
d25♂ 14.86 148.59 82.59 33.24 
d26♂ 14.53 145.3 82.46 33.19 
D0♂ 14.46 144.62 84.82 33.86 
D1♂ 12.18 121.8 84.56 33.8 
D2♂ 13.14 131.43 84.69 33.83 
D4♂ 12.24 122.41 82.29 33.15 
control d25♂ 
untreated 
14.66 146.64 81.59 32.93 
E2 d25♂ 
treated 
12.9 128.95 82.16 33.1 
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This table summarizes the RNA sequencing results obtained from PerkinElmer using the 
Illumina HiSeq 2000 sequencing system. The number of reads for each sample ranged from 
116.28 to 146.64 million base pairs. The percentage of those reads with Phred quality score or Q 
score of 30 or higher ranged from 81.59 to 85.14. This Q score is used to measure base calling 
accuracy. The mean Q score given to each base ranged from 32.93 to 34.01. This indicates that 
base call accuracy of this data set is between 99.9 to 99.99% and the probability of incorrect base 
call is 1 in 1,000 to 1 in 10,000. This table confirms that this transcriptome data set is very 
accurate and should be used for data analysis. 
 
FastQC 
Table 4. FastQC Report Basic Statistics 
Sample Total Sequences % Mean GC Content 
d24♀ 66950752 45 
d25♀ 65721535 45 
d26♀ 69390000 45 
D0♀ 62548792 45 
D4♀ 75191503 45 
D8♀ 58464804 45 
d24♂ 58137974 45 
d25♂ 74293998 45 
d26♂ 72648754 45 
D0♂ 72310073 46 
D1♂ 60898922 45 
D2♂ 65715502 46 
D4♂ 61203170 45 
control d25♂ untreated 73321177 46 
E2 d25♂ treated 64474138 46 
 
FastQC was used to check the quality of the raw high throughput mRNA sequencing reads 
obtained from PerkinElmer. All sequences were not filtered and sequence length was 100 base 
pairs. For every sample, the basic statistic parameters were set by FastQC. Total sequences for 
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each sample ranged from 58 to 75 million. The mean percentage of GC content of the sequences 
ranges from 45 to 46. High GC content indicates coding regions in these sequences. 
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Figure 1. Overall Representation of FastQC Report Quality Scores Across All Bases: (a) E2 
d25♂ treated, (b) control d25♂ untreated, (c) D0♂, (d) D0♀ 
 
Part (a) of this figure shows a failed per base sequence quality graph according to FastQC. 
However, the lack of quality in the first few base pairs of the sequence is normal, and there is not 
a huge difference between (a) and all the other parts of the figure. In addition, the low quality 
base pairs towards the end of the sequence are expected because of the sequencing chemistry. 
Parts (b), (c) and (d) all passed according to FastQC standards. Regardless of FastQC 
qualifications of passed and failed data sets, all of the scores are still very good and are within 
normal parameters. The difference between passed and failed per base sequence quality graphs is 
very slight and is discounted. The blue line in all four figures corresponds to the mean quality 
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score (Q score). These are representative QC reports from control untreated, E2 treated, and 
normal male and female gonad samples. All samples showed similar quality scores as the passed 
and failed figures shown here. 
 
 
 20 
 
 
 
Figure 2. Overall Representation of FastQC Report Quality Score Distribution Across All 
Sequences: (a) E2 d25♂ treated, (b) control d25♂ untreated, (c) D0♂, (d) D0♀ 
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This figure shows a great representation of the mean sequence quality of each sample. Every 
sample passed FastQC's per sequence quality check with average scores around 37 to 38. As 
previously mentioned, Q scores are used to measure base calling accuracy. FastQC indicates that 
base call accuracy of all samples are between 99.9 to 99.99% and the probability of incorrect 
base call is 1 in 1,000 to 1 in 10,000. 
From all these FastQC reports, these transcriptomes are of considerable high quality and 
accuracy to be utilized for discovering differentially expressed genes and transcripts. 
 
Gene Expression Analyses 
Table 5. Potential Gene Targets of Estrogen in Ovarian Development 
Gene D4 Male 
(average FPKM) 
Control Male 
(average FPKM) 
E2 Treated Male 
(average FPKM) 
Upregulation Fold by 
Estrogen 
DIO1 − 34.6153 122.152 3.529 
ABCA5 − 17.9194 51.80455 2.891 
SDSL − 50.3308 129.641 2.576 
NPHS2 8.50532 14.1093 36.0758 2.557 
GREB1 − 12.6886 27.8067 2.191 
IFIT3 4.18097 38.064 72.03505 1.892 
CFH − 69.3539 131.191 1.892 
 
Differential expression is quantified by fragments per kilobase of transcript per million mapped 
fragments (FPKM). FPKM is used by Cufflinks and Cuffdiff to standardize expression levels of 
each transcript. This takes into consideration the length and abundance of each transcript. Then 
FPKM values can be utilized to compare expression levels of different genes and transcripts 
[49]. Table 5 lists genes from highest to lowest upregulation fold by estrogen treatment. This 
upregulation fold value was obtained by dividing the E2 treated male FPKM values by the 
control male FPKM values. These genes are induced by exogenous estrogen treatment and could 
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be potential targets of estrogen during ovarian differentiation. This table provides a glimpse into 
novel genes involved in ovarian differentiation. DIO1, ABCA5, and SDSL show the highest 
upregulation in differential expression. These genes were further examined in the mouse 
GenitoUrinary Development Molecular Anatomy Project (GUDMAP), and show upregulation 
during ovarian development in mice in comparison to testes at the same stage. Thus, these genes 
are potentially highly conserved mammalian ovarian development factors and are likely to be 
estrogen responsive.  
 
 
Figure 3. Differential Expression Levels of NPHS2 gene 
Figure 3 shows an example of significantly changed differential expression of the NPHS2 gene. 
The expression level at day 4 postpartum in males is almost equivalent to male gonads cultured 
in control media but considerably less than expression levels of male gonads cultured in 
estrogen. This figure shows NPHS2 as a potential target of estrogen during ovarian 
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differentiation. NPHS2 expression in E2 treated males is induced by exogenous estrogen 
treatment and not by culture. 
 
Table 6. Top 10 Changed Gene Expression Levels from Male vs. Female at Each Key 
Developmental Stage 
Blue indicates genes increased in expression in males while pink shows those increased in 
females. 
Pre-gonadal 
Differentiation 
During Gonadal 
Differentiation 
Post-gonadal 
Differentiation 
AMH ALAS2 ALAS2 
ALAS2 ALDH1A1 ALDH1A1 
CALB1 CLU CLU 
CGA GSTM3 GSTM3 
CLU HBA2 HSD3B1 
CPA1 NDNL2 NDNL2 
HBA2 PDZK1IP1 PTGDS 
NDNL2 RNASEH1 RNASEH1 
SERPINA3 SERPINA3 SERPINA3 
TMEM52B TNNC1 TNNC1 
 
Note: Pre-gonadal differentiation refers to day 24 of gestation to day 2 postpartum in females 
and day 24 of gestation to day 0 postpartum in males. During gonadal differentiation refers to 
day 4 postpartum in females and day 1 to day 2 postpartum in males. Post-gonadal differentiation 
refers to day 8 postpartum in females and day 4 postpartum in males. 
This table shows the comparisons male vs. female for each gene listed. Genes shaded in light 
blue indicate higher differential expression in males than females. Genes shaded in light pink 
indicate higher differential expression in females than males. For example, in comparison to 
males, the gene ALAS2 is downregulated in females during all stages of sexual differentiation. 
The genes AMH and PTGDS are especially important due to their roles in testicular 
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differentiation. AMH is significantly upregulated in males during pre-gonadal differentiation. 
PTGDS is significantly upregulated in males during post-gonadal differentiation. 
 
Table 7. Known Testicular and Ovarian Genes with Significant Differential Expression at Each 
Stage of Gonadal Differentiation 
 ♂ pre ♂ during ♂ post ♀ pre ♀ during ♀ post 
AMH ↑ ↑ ↓ ↑   
DHH  ↑     
DMRT1 ↑ ↑ ↑    
FOXL2     ↑  
NR0B1    ↑   
PTGDS ↑ ↑ ↑ ↑  ↑ 
SOX9 ↑ ↑ ↓    
 
Note: Pre-gonadal differentiation refers to day 24 of gestation to day 2 postpartum in females 
and day 24 of gestation to day 0 postpartum in males. During gonadal differentiation refers to 
day 4 postpartum in females and day 1 to day 2 postpartum in males. Post-gonadal differentiation 
refers to day 8 postpartum in females and day 4 postpartum in males. 
Table 7 indicates whether each gene is upregulated or downregulated during each stage of 
gonadal differentiation with an up arrow or a down arrow respectively. AMH, DHH, DMRT1, 
PTGDS, and SOX9 all show significant gene expression in males during gonadal differentiation. 
This reaffirms their roles in testicular differentiation and validates our transcriptome analyses. 
FOXL2 shows significant gene expression in females during gonadal differentiation. This 
confirms its role in ovarian differentiation, which is consistent with previous studies in the 
tammar, mouse and human, again confirming our transcriptome analyses. 
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The genes in the following four figures show very little expression in female wallabies. No 
ovaries were collected for day 1 and day 2 postpartum. No testes were collected for day 8 
postpartum. There are notable differences in expression levels between females and males. 
 
 
Figure 4. Differential Expression Levels of AMH gene 
AMH expression levels were significantly higher at day 24 of gestation and day 0 postpartum in 
males. Levels were low at day 25 of gestation and day 4 postpartum in males. Differential 
expression fluctuates in males and is almost nonexistent in females. This figure reiterates this 
gene’s role in testicular differentiation. 
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Figure 5. Differential Expression Levels of DMRT1 gene 
DMRT1 expression levels were significantly higher at day 2 and day 4 postpartum in males. 
Levels were low at day 24 and day 25 of gestation. Differential expression is upregulated at a 
linear rate. This figure reiterates this gene’s role in testicular differentiation. 
 
 
Figure 6. Differential Expression of PTGDS gene 
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PTGDS expression levels were significantly higher at day 1 and day 4 postpartum in males. 
Levels were low at day 24 of gestation. Differential expression is upregulated at a linear rate. 
This figure reiterates this gene’s role in testicular differentiation. 
 
 
Figure 7. Differential Expression of SOX9 gene 
 SOX9 expression levels were particularly high at day 0 and day 2 postpartum in males. Levels 
were low at day 26 of gestation and day 1 and day 4 postpartum in males. Differential expression 
fluctuates in males and is almost nonexistent in females. This figure reiterates this gene’s role in 
testicular differentiation. 
 
Table 8. Potential Novel Genes Involved in Ovarian and Testicular Differentiation 
Genes 
AFP GSTM3 PDGFA 
ALAS2 NDNL2 SERPINA3 
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These genes were chosen through analyses of FPKM values for all stages of gonadal 
differentiation and focused on expression levels during gonadal differentiation for both males 
and females. AFP and PDGFA differential expression levels were investigated further. 
  
The genes in the following two figures show very little expression in female wallabies. No 
ovaries were collected for day 1 and day 2 postpartum. No testes were collected for day 8 
postpartum. There are notable differences in expression levels between females and males. 
 
 
Figure 8. Differential Expression of AFP gene 
AFP expression levels were particularly high at day 25 of gestation and day 1 postpartum in 
males. Levels were at its lowest at day 24 of gestation and low at day 26 of gestation in males. 
Differential expression essentially plateaus from day 25 of gestation to day 4 postpartum in 
males and is almost nonexistent in females. 
 
 29 
 
 
Figure 9. Differential Expression of PDGFA gene 
PDGFA expression levels were particularly high at day 26 of gestation and peaks on day 0 
postpartum in males. Levels were at low at day 24 of gestation in males. Differential expression 
is upregulated from day 24 of gestation to day 0 postpartum and is downregulated from day 0 to 
day 4 postpartum in males. In females, differential expression stays pretty level. 
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Figure 10. Principal Component Analysis (PCA) Graph of Transcriptome Samples 
This figure was composed to determine the relationships between each of the transcriptome 
samples by grouping them together. There are a few outliers that are especially interesting: day 4 
and day 8 females postpartum, E2 treated male and day 1 male postpartum. Day 4 and day 8 
females follow a different trajectory than the rest of the samples, which adheres to previous 
differential expression studies. E2 treated male also follows a different trajectory and lies close to 
day 4 female postpartum. Control male lies close to day 4 male postpartum as expected. During 
day 1 male postpartum, the gonad is known to undergo major transcriptional changes since this is 
around the time it commits to the testis pathway.
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Functional Annotation and Gene Ontology from Blast2GO 
 
Figure 11. Annotation Results from Blast2GO 
This figure was created by Blast2GO. No sequences were without Blast results indicating that all 
sequences were processed. There were about 25 thousands sequences without Blast hits after the 
BLAST step. There were about five thousand successful sequences with Blast results after the 
BLAST step. There were about five thousand successful sequences with mapping results after 
the mapping step. There were almost 20 thousand successful sequences that were annotated. 
There were 50 thousand sequences entered into Blast2GO for annotation. 
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Figure 12. GO-level distribution of Total Annotations from Blast2GO: P = biological process,  
F = molecular function, C = cellular component 
This figure was created by Blast2GO. It shows the overall distribution of gene ontology terms for 
each GO level for 173,830 annotations. A GO level is assigned by Blast2GO and shows the 
maximum depth of each GO term. Each term is divided into three different categories: biological 
process, molecular function, and cellular component. GO terms are created by the Gene 
Ontology Consortium to standardize gene function and product descriptions. 
 
The following tables list GO terms from Blast2GO in their respective categories for genes of 
interest.  
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Table 9. Gene Ontology Terms for Top Changed Gene Comparisons 
Gene Molecular Function Biological Processes Cellular Component 
ALAS2 5-aminolevulinate synthase activity 
coenzyme binding 
glycine binding 
protein binding 
pyridoxal phosphate binding 
cellular iron ion homeostasis 
erythrocyte differentiation 
heme biosynthetic process 
hemoglobin biosynthetic process 
oxygen homeostasis 
porphyrin-containing compound metabolic 
process 
protoporphyrinogen IX biosynthetic process 
response to hypoxia 
small molecule metabolic process 
mitochondrial inner 
membrane 
mitochondrial matrix 
mitochondrion 
ALDH1A1 Ras GTPase activator activity 
aldehyde dehydrogenase (NAD) 
activity 
androgen binding 
retinal dehydrogenase activity 
cellular aldehyde metabolic process 
ethanol oxidation 
positive regulation of Ras GTPase activity 
retinol metabolic process 
small molecule metabolic process 
xenobiotic metabolic process 
cytoplasm 
cytosol 
extracellular vesicular 
exosome 
AMH Growth factor activity 
Hormone activity 
Receptor binding 
Transforming growth factor beta 
receptor binding 
Müllerian duct regression 
Aging 
Cell-cell signaling 
Gonadal mesoderm development 
Positive regulation of: NF-kappaB 
transcription factor activity, gene expression 
Preantral ovarian follicle growth 
Response to: drug, organic cyclic compound 
Sex determination 
Sex differentiation 
Urogenital system development 
Cytoplasm 
Extracellular region 
Extracellular space 
APOE antioxidant activity 
beta-amyloid binding 
G-protein coupled receptor signaling pathway 
N-methyl-D-aspartate receptor clustering 
Golgi apparatus 
blood microparticle 
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cholesterol transporter activity 
heparin binding 
hydroxyapatite binding 
identical protein binding 
lipid binding 
lipid transporter activity 
lipoprotein particle binding 
low-density lipoprotein particle 
receptor binding 
metal chelating activity 
phosphatidylcholine-sterol O-
acyltransferase activator activity 
phospholipid binding 
protein binding 
protein homodimerization activity 
tau protein binding 
very-low-density lipoprotein 
particle receptor binding 
aging 
alpha-amino-3-hydroxy-5-methyl-4-isoxazole 
propionate selective glutamate receptor 
clustering 
artery morphogenesis 
cGMP-mediated signaling 
cell death 
cellular calcium ion homeostasis 
cellular response to: cholesterol, growth factor 
stimulus, interleukin-1 
cholesterol: catabolic process, efflux, 
homeostasis, metabolic process 
chylomicron remnant clearance 
cytoskeleton organization 
fatty acid homeostasis 
high-density lipoprotein particle: assembly, 
clearance, remodeling 
intracellular transport 
lipoprotein biosynthetic process 
lipoprotein catabolic process 
lipoprotein metabolic process 
long-chain fatty acid transport 
low-density lipoprotein particle remodeling 
maintenance of location in cell 
negative regulation of: MAP kinase activity, 
beta-amyloid formation, blood coagulation, 
blood vessel endothelial cell migration, 
cholesterol biosynthetic process, cholesterol 
efflux, dendritic spine development, dendritic 
spine maintenance, endothelial cell 
proliferation, inflammatory response, lipid 
biosynthetic process, lipid transport across 
chylomicron 
cytoplasm 
dendrite 
early endosome 
endocytic vesicle lumen 
extracellular matrix 
extracellular region 
extracellular space 
extracellular vesicular 
exosome 
extrinsic component of 
external side of plasma 
membrane 
high-density lipoprotein 
particle 
intermediate-density 
lipoprotein particle 
late endosome 
low-density lipoprotein 
particle 
membrane 
neuronal cell body 
nucleus 
plasma membrane 
very-low-density lipoprotein 
particle 
vesicle 
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blood brain barrier, neuron apoptotic process, 
neuron death, phospholipid efflux, platelet 
activation, postsynaptic membrane 
organization, presynaptic membrane 
organization 
nitric oxide mediated signal transduction 
oligodendrocyte differentiation 
peripheral nervous system axon regeneration 
phospholipid efflux 
phototransduction, visible light 
positive regulation of: axon extension, beta-
amyloid formation, cGMP biosynthetic 
process, cholesterol efflux, cholesterol 
esterification, dendritic spine development, 
dendritic spine maintenance, lipid biosynthetic 
process, lipid transport across blood brain 
barrier, low-density lipoprotein particle 
receptor catabolic process, membrane protein 
ectodomain proteolysis, neurofibrillary tangle 
assembly, neuron death, nitric-oxide synthase 
activity, phospholipid efflux, postsynaptic 
membrane organization, presynaptic 
membrane organization 
protein import 
receptor-mediated endocytosis 
regulation of: Cdc42 protein signal 
transduction, axon extension, beta-amyloid 
clearance, neuron death, neuronal synaptic 
plasticity, tau-protein kinase activity 
response to: dietary excess, ethanol, insulin, 
reactive oxygen species, retinoic acid 
retinoid metabolic process 
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reverse cholesterol transport 
small molecule metabolic process 
synaptic transmission, cholinergic 
triglyceride metabolic process 
vasodilation 
very-low density lipoprotein clearance 
very-low density lipoprotein remodeling 
C3 C5L2 anaphylatoxin chemotactic 
receptor binding 
endopeptidase inhibitor activity 
protein binding 
receptor binding 
G-protein coupled receptor signaling pathway 
complement activation 
complement activation, alternative pathway 
complement activation, classical pathway 
fatty acid metabolic process 
immune response 
inflammatory response 
innate immune response 
negative regulation of endopeptidase activity 
positive regulation of: G-protein coupled 
receptor protein signaling pathway, activation 
of membrane attack complex, angiogenesis, 
apoptotic cell clearance, glucose transport, 
lipid storage, protein phosphorylation, type IIa 
hypersensitivity, vascular endothelial growth 
factor production 
regulation of: complement activation, immune 
response, triglyceride biosynthetic process 
signal transduction 
blood microparticle 
extracellular region 
extracellular space 
extracellular vesicular 
exosome 
plasma membrane 
CA3 carbonate dehydratase activity 
nickel cation binding 
zinc ion binding 
bicarbonate transport 
one-carbon metabolic process 
response to ethanol 
response to oxidative stress 
small molecule metabolic process 
Cytosol 
CALB1 calcium ion binding cellular response to organic substance Axon 
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protein binding 
vitamin D binding 
zinc ion binding 
cytosolic calcium ion homeostasis 
locomotory behavior 
long-term memory 
metanephric collecting duct development 
metanephric connecting tubule development 
metanephric distal convoluted tubule 
development 
metanephric part of ureteric bud development 
regulation of synaptic plasticity 
retina layer formation 
short-term memory 
cytosol 
dendrite 
extracellular vesicular 
exosome 
neuronal cell body 
nucleus synapse 
CFD serine-type endopeptidase activity 
serine-type peptidase activity 
blood coagulation 
complement activation 
complement activation, alternative pathway 
innate immune response 
platelet activation 
platelet degranulatioon 
proteolysis 
extracellular region 
extracellular space 
extracellular vesicular 
exosome 
platelet alpha granule lumen 
CGA hormone activity 
protein binding 
cell-cell signaling 
cellular protein metabolic process 
cellular response to hormone stimulus 
developmental growth 
follicle-stimulating hormone secretion 
gonad development 
luteinizing hormone secretion 
negative regulation of organ growth 
peptide hormone processing 
positive regulation of cell migration 
positive regulation of cell proliferation 
positive regulation of transcription from RNA 
polymerase II promoter 
signal transduction 
Extracellular region 
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thyroid gland development 
thyroid hormone generation 
CLU NOT ATPase activity 
misfolded protein binding 
protein binding 
ubiquitin protein ligase binding 
blood coagulation 
cell morphogenesis 
central nervous system myelin maintenance 
chaperone-mediated protein complex 
assembly 
chaperone-mediated protein folding 
complement activation 
complement activation, classical pathway 
innate immune response intrinsic apoptotic 
signaling pathway 
lipid metabolic process 
microglial cell activation 
microglial cell proliferation 
negative regulation of beta-amyloid formation 
negative regulation of intrinsic apoptotic 
signaling pathway in response to DNA 
damage 
negative regulation of protein 
homooligomerization 
platelet activation 
platelet degranulation 
positive regulation of: NF-kappaB 
transcription factor activity, apoptotic process, 
beta-amyloid formation,  intrinsic apoptotic 
signaling pathway 
positive regulation of neurofibrillary tangle 
assembly, neuron death, nitric oxide 
biosynthetic process, proteasomal ubiquitin-
dependent protein catabolic process, tau-
protein kinase activity, tumor necrosis factor 
apical dendrite 
blood microparticle 
chromaffin granule 
cytoplasm 
cytosol 
endoplasmic reticulum 
extracellular matrix 
colocalizes with 
extracellular matrix 
extracellular region 
extracellular space 
extracellular vesicular 
exosome 
mitochondrial membrane 
mitochondrion 
neurofibrillary tangle 
nucleus 
perinuclear region of 
cytoplasm 
platelet alpha granule lumen 
spherical high-density 
lipoprotein particle 
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production 
protein import 
protein stabilization 
regulation of: beta-amyloid clearance, neuron 
death, neuronal signal transduction 
release of cytochrome c from mitochondria 
response to misfolded protein 
response to virus 
reverse cholesterol transport 
CPA1 Metallocarboxypeptidase activity 
Zinc ion binding 
proteolysis Extracellular space 
CTRB2 serine-type endopeptidase activity cobalamin metabolic process 
digestion 
extracellular matrix disassembly 
extracellular matrix organization 
proteolysis 
small molecule metabolic process 
vitamin metabolic process 
water-soluble vitamin metabolic process 
extracellular region 
extracellular space 
DIO1 selenium binding 
thyroxine 5’-deiodinase activity 
Cellular nitrogen compound metabolic process 
hormone biosynthetic process 
oxidation-reduction process 
small molecule metabolic process 
thyroid hormone generation 
endoplasmic reticulum 
membrane 
integral component of 
membrane 
plasma membrane 
GSTM3 enzyme binding 
glutathione binding 
glutathione transferase activity 
identical protein binding 
protein homodimerization activity 
cellular detoxification of nitrogen compound 
establishment of blood-nerve barrier 
glutathione derivative biosynthetic process 
glutathione metabolic process 
nitrobenzene metabolic process 
response to estrogen 
small molecule metabolic process 
xenobiotic catabolic process 
Cytoplasm 
cytosol 
extracellular vesicular 
exosome 
nucleus 
sperm fibrous sheath 
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xenobiotic metabolic process 
HBA2 Contributes to haptoglobin binding 
heme binding 
iron ion binding 
oxygen binding 
oxygen transporter activity 
contributes to peroxidase activity 
protein binding 
Biocarbonate transport 
Hydrogen peroxide catabolic process 
Oxidation-reduction process 
Oxygen transport 
Positive regulation of cell death 
Protein heterooligomerization 
Response to hydrogen peroxide 
Small molecular metabolic process 
Blood microparticle 
cytosol 
cytosolic small ribosomal 
subunit 
endocytic vesicle lumen 
extracellular region 
extracellular vesicular 
exosome 
haptoglobin-hemoglobin 
complex 
hemoglobin complex 
membrane 
HSD3B1 3-beta-hydroxy-delta5-steroid 
dehydrogenase activity 
Steroid delta-isomerase activity 
androgen biosynthetic process 
estrogen biosynthetic process 
glucocorticoid biosynthetic process 
mineralocorticoid biosynthetic process 
oxidation-reduction process 
small molecule metabolic process 
steroid biosynthetic process 
steroid metabolic process 
endoplasmic reticulum 
membrane 
integral component of 
membrane 
mitochondrial inner 
membrane 
mitochondrial 
intermembrane space 
smooth endoplasmic 
reticulum membrane 
IGFBP3 fibronectin binding 
insulin-like growth factor I binding 
insulin-like growth factor binding 
metal ion binding 
protein binding 
protein tyrosine phosphatase 
activator activity 
apoptotic process 
cellular protein metabolic process 
negative regulation of: cell proliferation, 
protein phosphorylation, signal transduction, 
smooth muscle cell migration, smooth muscle 
cell proliferation 
osteoblast differentiation 
positive regulation of: MAPK cascade, 
apoptotic process, catalytic activity, insulin-
extracellular region 
extracellular space 
extracellular vesicular 
exosome 
insulin-like growth factor 
binding protein complex 
nucleus 
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like growth factor receptor signaling pathway, 
myoblast differentiation 
protein phosphorylation 
regulation of cell growth 
regulation of glucose metabolic process 
type B pancreatic cell proliferation 
MGP calcium ion binding 
extracellular matrix structural 
constituent 
structural constituent of bone 
cartilage condensation 
cell differentiation 
ossification 
regulation of bone mineralization 
colocalizes with 
extracellular matrix 
extracellular vesicular 
exosome 
proteinaceous extracellular 
matrix 
NDNL2 Protein binding DNA recombination 
DNA repair 
positive regulation of protein ubiquitination 
regulation of growth 
Smc5-Smc6 complex 
Chromosome, telomeric 
region 
Cytoplasm 
nucleus 
PDZK1IP1   Extracellular vesicular 
exosome 
Integral component of 
membrane 
PTGDS Fatty acid binding 
Prostaglandin-D synthase activity 
Retinoid binding 
Transporter activity 
Arachidonic acid metabolic process 
Cyclooxygenase pathway 
Prostaglandin biosynthetic process 
Regulation of circadian sleep/wake cycle, 
sleep 
Response to glucocorticoid 
Small molecule metabolic process 
transport 
Golgi apparatus 
Endoplasmic reticulum 
membrane 
Extracellular region 
Extracellular space 
Extracellular vesicular 
exosome 
Nuclear membrane 
Perinuclear region of 
cytoplasm 
Rough endoplasmic 
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reticulum 
RNASEH1 RNA binding 
RNA-DNA hybrid ribonuclease 
activity 
Magnesium ion binding 
Nucleic acid binding 
Protein homodimerization activity 
Ribonuclease activity 
RNA catabolic process 
RNA phosphodiester bond hydrolysis 
RNA phosphodiester bond hydrolysis, 
endonucleolytic 
Mitochondrial DNA replication 
Mitochondrion 
nucleus 
SAA1 G-protein coupled receptor binding 
heparin binding 
acute-phase response 
innate immune response 
lymphocyte chemotaxis 
macrophage chemotaxis 
negative regulation of inflammatory response 
neutrophil chemotaxis 
platelet activation 
positive regulation of: cell adhesion, cytokine 
secretion, cytosolic calcium ion concentration, 
interleukin-1 secretion 
endocytic vesicle lumen 
extracellular region 
extracellular vesicular 
exosome 
high-density lipoprotein 
particle 
SERPINA3 DNA binding 
protein binding 
serine-type endopeptidase inhibitor 
activity 
acute-phase response 
inflammatory response 
maintenance of gastrointestinal epithelium 
negative regulation of endopeptidase activity 
regulation of lipid metabolic process 
regulation of proteolysis 
blood microparticle 
extracellular region 
extracellular space 
extracellular vesicular 
exosome 
intracellular 
nucleus 
TMEM52B   extracellular vesicular 
exosome 
integral component of 
membrane 
TNNC1 actin filament binding 
calcium ion binding 
calcium-dependent protein binding 
cardiac muscle contraction 
diaphragm contraction 
muscle filament sliding 
actin cytoskeleton 
cytosol 
mitochondrion 
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protein binding 
protein homodimerization activity 
troponin I binding 
troponin T binding 
regulation of ATPase activity 
regulation of muscle contraction 
regulation of muscle filament sliding speed 
response to metal ion 
ventricular cardiac muscle tissue 
morphogenesis 
NOT nucleolus 
nucleus 
troponin complex 
 
Table 10. Gene Ontology Terms for Potential Novel Genes 
Gene Molecular Function Biological Processes Cellular Component 
AFP metal ion binding SMAD protein signal transduction 
ovulation from ovarian follicle 
progesterone metabolic process 
transport 
Cytoplasm 
extracellular space 
PDGFA Collagen binding 
Growth factor activity 
Platelet-derived growth factor 
binding 
Platelet-derived growth factor 
receptor binding 
Contributes to platelet-derived 
growth factor receptor binding 
Platelet-derived growth factor 
receptor binding 
Protein binding  
Protein heterodimerization activity 
Protein homodimerization activity 
Fc-epsilon receptor signaling pathway 
Actin cytoskeleton organization 
Angiogenesis 
Blood coagulation 
Cell activation 
Cell projection assembly 
Cell-cell signaling embryo development 
Epidermal growth factor receptor signaling 
pathway 
Extracellular matrix organization 
Fibroblast growth factor receptor signaling 
pathway 
Hair follicle development 
Innate immune response 
Inner ear development 
Lung alveolus development 
Negative chemotaxis 
Golgi membrane 
Cell surface 
Endoplasmic reticulum 
lumen 
Extracellular region 
Extracellular space 
Microvillus 
Platelet alpha granule lumen 
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Negative regulation of phosphatidylinositol 
biosynthetic process 
Negative regulation of platelet activation 
Neurotrophin TRK receptor signaling pathway 
Organ morphogenesis 
Phosphatidylinositol-mediated signaling 
Platelet activation 
Platelet degranulation 
Platelet-derived growth factor receptor 
signaling pathway 
Positive regulation of: DNA replication, ERK1 
and ERK2 cascade, MAP kinase activity, 
MAPK cascade, cell division, cell migration, 
cell proliferation, fibroblast proliferation, 
mesenchymal cell proliferation, metanephric 
mesenchymal cell migration by platelet-derived 
growth factor receptor-beta signaling pathway,  
phosphatidylinositol 3-kinase signaling, protein 
autophosphorylation, protein kinase B signaling 
NOT regulation of DNA biosynthetic process 
Regulation of actin cytoskeleton organization 
Regulation of branching involved in salivary 
gland morphogenesis by epithelial-
mesenchymal signaling 
NOT regulation of glomerular mesangial cell 
proliferation 
Regulation of pepitdyl-tyrosine 
phosphorylation 
Regulation of smooth muscle cell migration 
Response to: drug, estradiol, hypoxia, 
substance, retinoic acid, wounding 
Skin development 
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Transforming growth factor beta receptor 
signaling pathway 
Wound healing 
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Discussion 
There is a tremendous need for comparative transcriptome analyses focusing on mammalian 
sexual development. Even though there is a vast amount of knowledge on this subject, many 
aspects of gonadal differentiation, especially ovarian development, have yet to be discovered. 
This thesis presents an important new comparative resource for the sex determination community 
with the analyses of high-depth transcriptomes during marsupial gonadal development. Due to 
time constraints, the vast amount of work went into extensive RNA sample prep and QC, and 
there was only a limited amount of time for data analyses. Even though the data analyses are 
rather rudimentary at this stage, results confirm previous findings on sexual differentiation, 
validating the utility of this data set. Analyses also revealed novel gene information and 
uncovered novel pathways induced by exogenous estrogen exposure. 
Testicular development in the tammar wallaby occurs during day 1 and day 2 postpartum. 
However, ovarian development occurs around day 4 postpartum at the molecular level and 
around day 8 postpartum histologically. Due to the window of time in which gonads were 
collected for these analyses, most of the differential expression data obtained pertains to genes 
involved in the testicular developmental pathway. Nevertheless, analyses did reveal significant 
upregulation of differential expression levels of FOXL2 in females during day 4 postpartum, 
which is during ovarian differentiation. This reaffirms the conserved role of FOXL2 in ovarian 
differentiation in mice, humans, and the tammar wallaby and its noninvolvement in testicular 
differentiation [16,24,29]. There was significant upregulation of differential expression of desert 
hedgehog (DHH), during day 1 postpartum in males, which is during testicular differentiation. 
This data is consistent with previous research stating the importance of DHH in testicular 
differentiation especially the early development of Leydig cells in mice and humans. In addition, 
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it confirms the conserved role of DHH in the tammar wallaby and eutherian mammals in the 
male gonadal pathway [10,17,21]. Nuclear receptor subfamily 0, group B, member 1 (NR0B1) 
was upregulated during day 24 of gestation in females. The role of NR0B1 during gonadal 
differentiation is unclear due to its characteristic of acting in a dose-dependent manner in mice 
and humans [3,9,15,36]. Previous studies have opposing views on whether it plays any role in 
gonadal development and whether it has roles in both testicular and ovarian differentiation 
[14,15,25]. Unlike mice and humans, NR0B1 is located on autosomal chromosome 5 in the 
tammar wallaby and not on the X-chromosome [14,17]. This gene can act as a pro-ovary gene 
consistent with its early upregulation in the ovary in the tammar. Nevertheless, more studies need 
to be done to clarify NR0B1’s role in sexual differentiation. 
Table 7 and Figure 4 show considerable differential expression levels of AMH throughout each 
stage of testicular differentiation and during pre-ovarian differentiation. These figures 
recapitulate the conserved importance of AMH in supporting male urogenital differentiation and 
development [2,17,44,50]. Furthermore, these data corroborate those seen previously for AMH in 
the tammar wallaby [16]. Results also revealed significant upregulation of doublesex and mab-3 
related transcription factor 1 (DMRT1) in males, especially from day 26 of gestation to day 4 
postpartum growing at an increasing rate. Prior studies indicate that DMRT1 upregulation in 
males is highly conserved among all vertebrates in the testes, and show it has a vital role in mice 
during postnatal testicular differentiation [15,25,28,30]. These studies are consistent with 
expression levels found in the tammar wallaby and highlight the relevance of this gene in male 
development in all vertebrates including the tammar. Similarly to DMRT1, the expression levels 
of PTGDS, prostaglandin D2 synthase, increased at linear rate in males. This follows with 
research on the importance of PTGDS in testicular differentiation and the development of Sertoli 
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cells [21,36,47]. Lastly, SOX9 is differentially expressed during all stages of male gonadal 
differentiation and is barely expressed in females. This data stresses the established and 
conserved role of SOX9 in promoting testicular formation and differentiation in all vertebrates 
including the tammar wallaby [1,9,14,21,28,45,47]. Previous studies done on the tammar 
wallaby show similar expression patterns, which reiterates this gene’s role conservation in 
eutherians and marsupials [15,16,45]. Taken together, these analyses validate the transcriptomes 
as a viable resource and a great representation of key sexual differentiation genes. 
Besides known sexual differentiation data, information on potential novel genes involved in 
gonadal differentiation in the tammar wallaby can be obtained from expression analyses. Based 
on analyses of significant expression levels during periods of testicular and ovarian 
differentiation, a list of potential novel genes was attained. These include AFP, ALAS2, GSTM3, 
NDNL2, PDGFA, and SERPINA3. For instance in Figure 9, platelet-derived growth factor 
subunit A (PDGFA) had substantially high expression levels during testicular differentiation and 
low levels in females. This indicates the likelihood of PDGFA being relevant in male gonadal 
development. A few studies briefly mention PDGF and PDGFA potentially being part of SOX9 
localization and the development of Leydig cells [21,25,47,51]. Moreover in Figure 8, alpha-
fetoprotein (AFP) also had particularly high expression levels during all stages of male gonadal 
differentiation and very low levels in females especially during ovarian differentiation. This data 
illustrates the prospect of AFP being a component of the male developmental pathway. None of 
the GO terms listed in Table 10 indicate any role in gonadal development for AFP and PDGFA. 
More studies such as immunohistochemistry need to be done for both PDGFA and AFP to 
confirm their importance in testicular differentiation. 
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Additionally, differential expression data were obtained from male gonads cultured in control 
media and in estrogen media. Preliminary data suggest that a plethora of genes were affected by 
exogenous estrogen exposure. In comparison to expression levels of gonads treated with control 
media, various genes were upregulated and downregulated on many levels due to exogenous 
estrogen exposure. These genes could potentially play a significant part of gonadal 
differentiation and could provide clues to how exogenous estrogen can activate estrogen 
receptors leading to the ovarian phenotype. As previously mentioned, exogenous estrogen 
exposure of the marsupial XY gonad results in complete sex reversal and ovarian development. 
Both estrogen receptors in the tammar are shown have a high degree of sequence homology to 
humans, mice and other vertebrates [11]. Therefore, further analyses can be performed on mice 
and humans to verify the effects of exogenous estrogen on the expression levels of the affected 
genes and their relevance in sexual differentiation. Many of the genes I identified to be 
upregulated in the estrogen cultured gonad were also known to be significantly differentially 
expressed and upregulated during ovarian development in the mouse (using GUDMAP). Such 
genes are highly conserved and are novel factors in the female developmental pathway that will 
form the topic of future investigations in the development of the mammalian ovary.  
Although a great deal of information was obtained, there are limitations to how much insight the 
initial data analyses will reveal about ovarian differentiation. Despite the enormous coverage of 
the reference tammar wallaby genome, there are some reads from the created transcriptomes that 
will not be mappable. To reduce the amount of unmapped reads, the genomes of two other 
marsupials, the opossum and Tasmanian devil, can be used to aid in read annotation, as well as 
the human and mouse genomes. However, it will only align those reads that are highly conserved 
across these species. In addition, the gene SRY was not able to be pulled from the data analyses 
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due to different alignment tools calling it different genes. This could potentially be the case for 
other divergent genes that could not be mapped. A new annotation of the tammar genome is 
pending release in 2015 and will significantly improve the utility of this data in future analyses.  
Furthermore, the data analyses only provides information about tammar wallaby transcriptomes 
and therefore more work will need to be done to create transcriptomes for the aromatase 
knockout mouse (ArKO) and the human cell line NT2/D1. The current tammar transcriptomes 
described in this thesis show normal gonadal development, the effects of estrogen in the gonad, 
and mentions some possible targets of environmental endocrine disrupters (EEDs) in the gonads. 
However, the specific interests of this thesis pertain to genes that are somatic cell specific 
meaning the supporting cell lineage and totipotent germ cells of the ovary and testis. NT2/D1 is a 
human pluripotent embryonal carcinoma cell line that was found to express both estrogen 
receptors, to be an excellent model for male gonadal development, express SRY and SOX9, and 
can respond to exogenous estrogen [5,52]. By developing transcriptomes with exogenous 
estrogen treatment in the tammar wallaby, NT2/D1 cell line and ARKO mouse, developmental 
researchers can perform comparative analyses to isolate somatic cell specific estrogen responsive 
genes. From those studies, potential genes involved in mammalian ovarian differentiation that 
trigger disorders of sexual development (DSDs), and are targets of estrogenic EEDs could be 
discovered. With this valuable data, prospective treatments could possibly be developed to treat 
DSDs and prevent future exposure of humans to EEDs. 
Conclusion 
The tammar wallaby, Macropus eugenii, is a novel and important new genetic model for research 
in human development especially sex determination and sexual differentiation. With the ever 
increasing rate and occurrence of disorders of sexual development (DSDs), comparative studies 
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such as this one are going to be critical in determining the key events in sexual differentiation in 
all mammals including humans. Transcriptomes from this study could potentially lead to 
treatments for DSDs and reveal new information about ovarian differentiation in mammals. 
These results show a lot of similarities, but also some interesting differences from mouse and 
human studies. Overall, this is a viable transcriptome resource and a good comparative data set 
to uncover conserved and novel genes regulating mammalian gonad formation. This thesis 
provides the first transcriptome analyses investigating the role of estrogen in sex reversal in the 
mammalian gonad. 
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